Chemotherapy before surgery for advanced gallbladder cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether giving chemotherapy before surgery helps people with locally advanced gallbladder cancer that can still be removed. It may improve outcomes by shrinking the tumor beforehand.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have gallbladder cancer that is advanced but can still be removed with surgery.
- Your overall health status allows you to be up and active (ECOG score 0-2).
- If you have already had gallbladder removal, there must be signs of leftover disease on scans, or a history of bile spill or piecemeal removal.
- You do not have distant spread (metastasis) or certain major blood vessel involvement.
- You are not pregnant and are willing to follow the study protocol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether receiving chemotherapy (cisplatin, gemcitabine, and nab-paclitaxel) before surgery can improve outcomes for people with high-risk bile duct or gallbladder cancer. It compares this approach to going straight to surgery.
This trial tests whether combining an immunotherapy drug (AK112) with chemotherapy can shrink advanced gallbladder cancer enough to make surgery possible. The goal is to give patients a chance at curative surgery who otherwise might not have one.
This trial tests a combination of chemotherapy drugs given before surgery for locally advanced stomach or gastroesophageal junction cancer. It aims to see if this approach helps shrink the tumor and improve outcomes.
This trial tests giving chemotherapy before any surgery to people with borderline resectable or locally advanced pancreatic cancer. The goal is to shrink the tumor, which may make surgery more successful and improve outcomes.
This trial tests a combination of chemotherapy, an immunotherapy drug (adebrelimab), and a drug to boost white blood cells (mecapegfilgrastim) before surgery for people with biliary tract cancer. The goal is to see if this approach can shrink the tumor enough to make surgery possible.
This trial tests a type of radiation therapy for people with advanced gallbladder cancer that cannot be removed by surgery. It is for those whose cancer has not spread to other parts of the body and has stayed stable or improved after initial chemotherapy.
Hear when a new Gall Bladder Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.